Blog Archives

Understanding the implications in cognitive-dominant MS.

4/10/2021

While multiple sclerosis (MS) is often considered a disease that presents with impaired motor function, a recent presentation at the ACTRIMS 2021 virtual conference shared an analysis of two ongoing studies and the degree to which signs of cognitive dysfunction in cases of relapsing-remitting MS (RMSS) may precede any motor issues.

2 Comments

What a NeuroQuant® image can tell us about MS.

4/5/2021

1 Comment

And why we should include it in our assessment protocols.

In considering how we can best gauge brain health or the progression of a known disorder, practitioners do have many tools we can employ to get a truly comprehensive perspective to determine the most appropriate therapy.

1 Comment

Is there support for the efficacy of memantine in MS?

4/1/2021

1 Comment

In a recent review, scientists looked at findings from several clinical trials that evaluated whether memantine, a glutamate-signaling suppressor, might prove to have any efficacy when used in patients suffering with multiple sclerosis (MS).

A bit of background…
As an abundant chemical messenger in the brain, glutamate plays a vital role in the functions of learning and memory, but in large amounts can impose significant negative impacts.

1 Comment

The relationship between glutamate and GABA.

4/1/2021

1 Comment

How can we reduce excess glutamate?

As the most abundant neurotransmitter in our nervous system, glutamate plays a critical role in normal brain functioning and requires that its levels must be well regulated in order to avoid either an excess or dearth of this important chemical messenger.

1 Comment

MS in the NEWS

Understanding the implications in cognitive-dominant MS.

What a NeuroQuant® image can tell us about MS.

And why we should include it in our assessment protocols.

Is there support for the efficacy of memantine in MS?

The relationship between glutamate and GABA.

Author

Archives

Categories

SITE MAP

Location

Telephone

Email